Apontis Pharma AG (XTER:APPH) Total Inventories : €5.47 Mil (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Apontis Pharma AG Total Inventories?

Apontis Pharma AG's total inventories for the quarter that ended in Dec. 2024 was €5.47 Mil. Apontis Pharma AG's average total inventories from the quarter that ended in Jun. 2024 to the quarter that ended in Dec. 2024 was €6.25 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Apontis Pharma AG's Net-Net Working Capital per share for the quarter that ended in Dec. 2024 was €0.59.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Apontis Pharma AG's Days Inventory for the six months ended in Dec. 2024 was 95.90.

Inventory Turnover measures how fast the company turns over its inventory within a year. Apontis Pharma AG's Inventory Turnover for the quarter that ended in Dec. 2024 was 1.90.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Apontis Pharma AG's Inventory-to-Revenue for the quarter that ended in Dec. 2024 was 0.24.

Apontis Pharma AG Total Inventories Historical Data

The historical data trend for Apontis Pharma AG's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Apontis Pharma AG Total Inventories Chart

Apontis Pharma AG Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Inventories

Get a 7-Day Free Trial

2.92

4.60

3.16

5.78

5.47

Apontis Pharma AG Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Total Inventories	Get a 7-Day Free Trial							3.16	4.57	5.78	7.04	5.47

Apontis Pharma AG Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

Apontis Pharma AG (XTER:APPH) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Apontis Pharma AG's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2024 is

	Net-Net Working Capital Per Share (Q: Dec. 2024 )
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(15.455	+	0.75 * 0.067	+	0.5 * 5.468	-	13.357
-	0	-	0)	/	8.330
=	0.59

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Apontis Pharma AG's Days Inventory for the six months ended in Dec. 2024 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Dec. 2024 )	/	Cost of Goods Sold (Q: Dec. 2024 )	*	Days in Period
	=	6.2535	/	11.9	*	365 / 2
	=	95.90

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Apontis Pharma AG's Inventory Turnover for the quarter that ended in Dec. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: Dec. 2024 )	/	Average Total Inventories (Q: Dec. 2024 )
	=	11.9	/	6.2535
	=	1.90

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Apontis Pharma AG's Inventory to Revenue for the quarter that ended in Dec. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Dec. 2024 )	/	Revenue (Q: Dec. 2024 )
	=	6.2535	/	25.741
	=	0.24

Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.

Apontis Pharma AG Total Inventories Related Terms

Thank you for viewing the detailed overview of Apontis Pharma AG's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.

Apontis Pharma AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Apontis Pharma AG (XTER:APPH) » Definitions » Total Inventories

Comparable Companies

Traded in Other Exchanges

N/A

Address

Rolf-Schwarz-Schutte-Platz 1, Monheim, BY, DEU, 40789

Website

https://www.apontis-pharma.de

Apontis Pharma AG is a pharmaceutical company specializing in single pills in Germany. single pills combine two to three generic active ingredients in a single dosage form. The company develops, promotes, and sells a broad portfolio of single pills and other pharmaceutical products, with a special focus on cardiovascular diseases. The company markets drugs in the disease areas of respiratory diseases and diabetes as part of co-marketing/co-promotion.

Executives

Bruno Wohlschlegel	Board of Directors
Thomas Milz	Board of Directors
Thomas Zimmermann	Chief Financial Officer
Karlheinz Gast	Board of Directors

Apontis Pharma AG Headlines

No Headlines